APOE and obesity due to melanocortin 4 receptor deficiency: In our recently published manuscript (Virtue et al., 2017), we found that global miR-155 deletion in an atherosclerotic mouse background (ApoE knockout mice) improved atherosclerosis but resulted in obesity, NAFLD, and hyperinsulinemia without insulin resistance.